Position in PCVX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$667,018,439
+$229,492 QoQ
Shares Held
11,474,599
0.0% QoQ
Ownership
7.71%
of shares outstanding
% of Portfolio
5.87%
of 13F equity value
Holder Rank
#5
of 325 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RA CAPITAL MANAGEMENT, L.P. holds $11,082,969,028 across 75 Biotechnology names. PCVX ranks #4 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
10,281,496 | $2,742,280,613 | |
| 2 | PBLS |
Parabilis Medicines, Inc.
|
28,933,371 | $791,906,364 | |
| 3 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
6,666,837 | $740,218,912 | |
| 4 | PCVX |
Vaxcyte, Inc.
This page
|
11,474,599 | $667,018,439 | |
| 5 | SION |
Sionna Therapeutics, Inc.
|
9,905,045 | $435,722,929 | |
| 6 | TYRA |
Tyra Biosciences, Inc.
|
12,198,625 | $389,624,082 | |
| 7 | EWTX |
Edgewise Therapeutics, Inc.
|
8,392,730 | $340,996,619 | |
| 8 | NAMS |
NewAmsterdam Pharma Co N.V.
|
9,883,524 | $330,779,298 |
All Filings in PCVX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $667,018,439 | 11,474,599 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $666,788,947 | 11,474,599 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $753,953,947 | 12,974,599 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $494,832,997 | 10,724,599 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $431,014,995 | 11,965,991 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $389,014,367 | 11,965,991 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $460,262,266 | 12,189,149 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $711,297,093 | 8,689,190 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $992,913,741 | 8,689,190 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $619,465,464 | 8,203,754 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $560,398,435 | 8,203,754 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $495,570,751 | 7,891,254 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $402,296,128 | 7,891,254 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $394,089,224 | 7,891,254 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $273,276,199 | 7,291,254 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $280,865,159 | 5,857,459 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $109,948,872 | 4,581,203 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $99,686,977 | 4,581,203 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $110,636,052 | 4,581,203 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $100,880,638 | 4,240,464 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $98,863,465 | 3,896,865 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $87,019,338 | 3,865,808 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $76,349,708 | 3,865,808 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $98,593,272 | 3,710,699 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $260,914,932 | 5,283,818 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $173,513,011 | 5,489,181 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||